Journal article · 2026 · Open access

THE IMMUNE SYSTEM IN ALZHEIMER'S DISEASE: INNATE AND ADAPTIVE IMMUNITY, NEUROINFLAMMATION, AND THERAPEUTIC APPROACHES

Amal A. Abdulbaqi

TPM Testing, psychometrics, methodology in applied psychology · Published 9 January 2026 · DOI 10.5281/zenodo.18197426

Open PDFView at the publisherCite this paper

In brief

“THE IMMUNE SYSTEM IN ALZHEIMER'S DISEASE: INNATE AND ADAPTIVE IMMUNITY, NEUROINFLAMMATION, AND THERAPEUTIC APPROACHES” is a 2026 journal article by Amal A. Abdulbaqi, published in TPM Testing, psychometrics, methodology in applied psychology. OpenAlex counts 0 citations as of 18 November 2026. It is open access under a CC BY-ND licence: the full text is free to read at TPM Testing, psychometrics, methodology in applied psychology.

Citations
0
References
29
Authors
1

Abstract

Alzheimer’s disease (AD) is a neurodegenerative disorder characterized pathologically by extracellular amyloid-β (Aβ) plaques and intracellular tau neurofibrillary tangles. Beyond these hallmark lesions, a growing body of evidence indicates that the immune system plays a pivotal role in AD pathogenesis. Neuroinflammatory processes – driven by both the brain’s innate immune cells (e.g. microglia, astrocytes) and components of the adaptive immune system (e.g. T and B lymphocytes) – are now recognized as key mediators of neuronal injury and disease progression. Genetic risk factors for late-onset AD notably include several genes associated with immune functions, underscoring the connection between immunity and neurodegeneration. Microglial activation in response to Aβ and tau can be double-edged: acutely, microglia may phagocytose Aβ and protect neurons, but chronic activation leads to release of pro-inflammatory cytokines, complement components, and other neurotoxic factors that exacerbate synaptic dysfunction and neuronal loss. Similarly, peripheral immune cells infiltrating the aging or diseased brain – including CD8+ and CD4+ T cells, natural killer cells, neutrophils, and others – have been implicated in amplifying neuroinflammation and modulating AD pathology. This review provides a comprehensive overview of the role of the immune system in AD, covering innate immunity (microglial activation states, inflammasome signaling, complement cascade, astrocyte-mediated responses), adaptive immunity (T cell and B cell responses within the central nervous system), the interplay between chronic neuroinflammation and AD pathogenesis, cytokine profiles in AD patients, disruption of the blood-brain barrier and immune trafficking, and the influence of peripheral immune factors. We also discuss emerging immune-based therapeutic strategies for AD – ranging from anti-amyloid immunotherapies and vaccines to approaches aiming to temper detrimental inflammation or boost beneficial immune responses. Understanding the multifaceted role of immunity in AD offers promising avenues for intervention and biomarkers. Therapeutic modulation of the immune system – carefully calibrated to suppress harmful inflammation while preserving or enhancing clearance of pathological proteins – may hold the key to altering the course of AD.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Abdulbaqi, A. A. (2026). THE IMMUNE SYSTEM IN ALZHEIMER'S DISEASE: INNATE AND ADAPTIVE IMMUNITY, NEUROINFLAMMATION, AND THERAPEUTIC APPROACHES. TPM Testing, psychometrics, methodology in applied psychology. https://doi.org/10.5281/zenodo.18197426

MLA 9

Abdulbaqi, Amal A. “THE IMMUNE SYSTEM IN ALZHEIMER'S DISEASE: INNATE AND ADAPTIVE IMMUNITY, NEUROINFLAMMATION, AND THERAPEUTIC APPROACHES.” TPM Testing, psychometrics, methodology in applied psychology, 2026. https://doi.org/10.5281/zenodo.18197426.

Chicago

Abdulbaqi, Amal A. 2026. “THE IMMUNE SYSTEM IN ALZHEIMER'S DISEASE: INNATE AND ADAPTIVE IMMUNITY, NEUROINFLAMMATION, AND THERAPEUTIC APPROACHES.” TPM Testing, psychometrics, methodology in applied psychology. https://doi.org/10.5281/zenodo.18197426.

Harvard

Abdulbaqi, A. A. (2026) ‘THE IMMUNE SYSTEM IN ALZHEIMER'S DISEASE: INNATE AND ADAPTIVE IMMUNITY, NEUROINFLAMMATION, AND THERAPEUTIC APPROACHES’, TPM Testing, psychometrics, methodology in applied psychology. doi:10.5281/zenodo.18197426.

IEEE

A. A. Abdulbaqi, “THE IMMUNE SYSTEM IN ALZHEIMER'S DISEASE: INNATE AND ADAPTIVE IMMUNITY, NEUROINFLAMMATION, AND THERAPEUTIC APPROACHES,” TPM Testing, psychometrics, methodology in applied psychology, 2026, doi: 10.5281/zenodo.18197426.

BibTeX

@article{abdulbaqi2026immune,
  title     = {{THE IMMUNE SYSTEM IN ALZHEIMER'S DISEASE: INNATE AND ADAPTIVE IMMUNITY, NEUROINFLAMMATION, AND THERAPEUTIC APPROACHES}},
  author    = {Abdulbaqi, Amal A.},
  journal   = {TPM Testing, psychometrics, methodology in applied psychology},
  year      = {2026},
  doi       = {10.5281/zenodo.18197426},
  url       = {https://doi.org/10.5281/zenodo.18197426}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms

  • Alzheimer's disease
  • neuroinflammation
  • innate immunity
  • adaptive immunity
  • microglial activation
  • astrocytes
  • T cells
  • B cells

Work with this paper

Most-cited papers in Neuroscience

All highly cited Neuroscience papers

Questions about this paper

How do I cite this paper in APA style?

Abdulbaqi, A. A. (2026). THE IMMUNE SYSTEM IN ALZHEIMER'S DISEASE: INNATE AND ADAPTIVE IMMUNITY, NEUROINFLAMMATION, AND THERAPEUTIC APPROACHES. TPM Testing, psychometrics, methodology in applied psychology. https://doi.org/10.5281/zenodo.18197426

How many times has this paper been cited?

0 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at TPM Testing, psychometrics, methodology in applied psychology: sign in and open the PDF from this page.

Who wrote this paper?

Amal A. Abdulbaqi.

What is the DOI of this paper?

10.5281/zenodo.18197426, permanently at https://doi.org/10.5281/zenodo.18197426. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.